CJC-1295 DAC 5mg

CJC-1295 with DAC – 2 mg | For Research Use Only – Not for Human Consumption

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic tetrasubstituted analog of growth hormone-releasing hormone (GHRH 1–29), developed to enhance and sustain endogenous growth hormone (GH) secretion in preclinical models. The covalent attachment of a Drug Affinity Complex (DAC) to the peptide confers prolonged systemic half-life via albumin binding, enabling stable elevation of both GH and insulin-like growth factor-1 (IGF-1) levels over an extended period.

Mechanistic Overview

CJC-1295 acts as a GHRH receptor agonist, stimulating pituitary somatotrophs to release GH in a physiologically pulsatile manner. The incorporation of DAC enables reversible binding to serum albumin, thereby protecting the peptide from proteolytic degradation and extending its plasma residence time up to 8–10 days in research models.

Key investigational effects include:

• Stimulation of GH and IGF-1 release, mimicking endogenous hormone dynamics

• Promotion of anabolic activity, including muscle hypertrophy and protein synthesis

• Support for lipolysis and fat metabolism regulation

• Improved recovery and repair of musculoskeletal tissue in preclinical models

• Modulation of metabolic pathways linked to cellular regeneration and longevity

Research Applications

CJC-1295 with DAC is employed in in vitro and in vivo studies exploring:

• Growth hormone deficiency modeling and replacement strategies

• Anabolic and anti-catabolic mechanisms in muscle tissue

• GH/IGF-1 axis regulation in metabolic and endocrine disorders

• Age-related decline in somatotropic activity

• Extended-release peptide delivery and pharmacokinetics

The extended half-life and pulsatile GH stimulation profile make CJC-1295 with DAC ideal for studying long-acting peptide therapeutics and hormonal regulation mechanisms.

Product Specifications

• Peptide Content: 2 mg (lyophilized)

• Modification: Tetrasubstituted GHRH analog with DAC

• Purity: >98% (validated via HPLC & MS)

• Storage: Store lyophilized at –20°C; refrigerate reconstituted peptide at 2–8°C and use within designated research timeline

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.

Bio Peptide Technologies is a chemical supplier. Bio Peptide Technologies is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Bio Peptide Technologies is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

All products are sold for research, laboratory, or analytical purposes only and are not for human consumption.

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

1. Research Use Only: All products provided by Bio Peptide Technologies are intended solely for in-vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions.

2. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption